Nasal Atomizer Devices, the Safe and Painless Way to Deliver Nasal Medications
Nasal atomizer devices are used to administer drugs through the nasal mucosa. The nasal route is considered over the conventional oral route of administration in some cases due to the rapid absorption of the drug is accompanied by more efficient drug administration. Thus, it is a more desirable route for non-invasive vaccination and specific drug delivery. Nasal drugs are widely used as topical treatments to ease symptoms such as cough, colds, sore throats, and flu.
Nasal atomizer devices have revolutionized the healthcare system providing a faster, more reliable, and convenient method of delivering medication. Nasal atomizer devices are now easily available over-the-counter for most types of nasal diseases. Most common uses of this type of drug delivery device are inhalation of the drug aerosols or aerosol spray which are usually made up of either saline or alcohol.
Nasal atomizer devices provide an effective way of administering drugs to help alleviate nasal congestion, headache, and other common ailments associated with the nose. Moreover, these devices provides relief from cold and flu symptoms by inhaling the vaporized drug mist into the respiratory tract and thus stimulating the mucous lining that in turn dries up the mucus thereby preventing the virus and bacteria to thrive.
Nasal atomizer devices can also be used as alternate delivery systems for inhaled medicines. Inhalers are used to treat colds and flu, as well as to ease symptoms associated with allergies including coughing, runny nose, and congestion. The nasal delivery of medicine through nasal sprays and atomizers has also helped increase the speed and effectiveness of drug delivery for at-home use. Nasal spray delivery systems such as the nasal atomizer devices are very convenient and are available in different sizes to accommodate the users' different needs.
Currently, nasal atomizer devices are used to treat allergic rhinitis and sinusitis. Sinusitis is inflammation of the mucous membranes that line the sinuses. The medication dupilumab (Dupixent) has been approved in Germany since October 2019 for the treatment of severe chronic sinusitis and nasal polyps in adults.
Comments
Post a Comment